ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,068Medicare Part D Prescriptions Filled, Including Refills

Rank: 128 out of 780

$1.01M Total Retail Price of All Prescriptions

Rank: 67 out of 780

904 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 904 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 904 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 9,186 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
AMLODIPINE BESYLATE 582 407 1 4
SIMVASTATIN 575 377 2 2
LISINOPRIL 503 307 3 6
HYDROCODONE-ACETAMINOPHEN 447 127 S3 4 1
OMEPRAZOLE 405 234 5 3
TRAMADOL HCL 384 234 6 15
LEVOTHYROXINE SODIUM 329 208 7 5
PRAVASTATIN SODIUM 302 185 8 9
ZOLPIDEM TARTRATE 285 103 9 17
MELOXICAM 282 142 10 16
FLUTICASONE PROPIONATE 266 165 11 41
METFORMIN HCL 265 161 12 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 241 130 13 26
CLONIDINE HCL 219 120 14 28
ATORVASTATIN CALCIUM 217 148 15 12
CITALOPRAM HBR 215 134 16 23
POTASSIUM CHLORIDE 213 122 17 11
LOSARTAN POTASSIUM 212 149 18 18
GABAPENTIN 212 110 18 13
FUROSEMIDE 198 126 20 7
CARVEDILOL 194 112 21 14
SPIRIVA 180 95 22 72
PANTOPRAZOLE SODIUM 176 110 23 25
METFORMIN HCL ER 174 99 24 43
GLIMEPIRIDE 168 110 25 30
NEXIUM 156 103 26 22
LOSARTAN-HYDROCHLOROTHIAZIDE 141 96 27 33
CYCLOBENZAPRINE HCL 130 37 R 28 42
METOPROLOL TARTRATE 128 96 29 19
CRESTOR 126 58 30 32
BUMETANIDE 126 56 30 96
ADVAIR DISKUS 125 67 32 68
SINGULAIR 118 79 33 73
OXYBUTYNIN CHLORIDE ER 117 84 34 169
TRAZODONE HCL 114 70 35 35
JANUVIA 107 57 36 85
SERTRALINE HCL 106 75 37 27
CIPROFLOXACIN HCL 106 59 37 49
CLOPIDOGREL 105 91 39 34
WARFARIN SODIUM 105 61 39 24
HYDRALAZINE HCL 103 76 41 54
METOPROLOL SUCCINATE 103 52 41 20
LEVETIRACETAM 102 70 43 130
AZITHROMYCIN 96 48 44 38
FLUOXETINE HCL 91 35 45 65
KLOR-CON M20 86 45 46 57
TAMSULOSIN HCL 84 69 47 36
BYSTOLIC 82 66 48 118
ALLOPURINOL 81 48 49 29
DOXAZOSIN MESYLATE 79 58 50 97
NIFEDIPINE ER 76 65 51 115
DIOVAN HCT 76 46 51 75
MORPHINE SULFATE ER 72 0 S2 53 141
HYDROCHLOROTHIAZIDE 71 51 54 10
AMOXICILLIN 70 38 55 99
CYMBALTA 70 43 55 51
ATENOLOL 70 31 55 21
KLOR-CON 10 69 45 58 90
NAMENDA 69 63 58 46
METHOCARBAMOL 68 15 R 60 84
PROAIR HFA 68 44 60 62
RANITIDINE HCL 65 30 62 39
MONTELUKAST SODIUM 64 39 63 120
PLAVIX 64 52 63 45
ZETIA 61 24 65 94
ROPINIROLE HCL 60 19 66 87
LEVOFLOXACIN 58 43 67 76
DONEPEZIL HCL 57 47 68 31
LANTUS SOLOSTAR 56 25 69 121
MECLIZINE HCL 55 42 70 83
TRIAMTERENE-HCTZ 54 15 71 37
ESCITALOPRAM OXALATE 52 23 72 61
NORTRIPTYLINE HCL 52 36 72 210
LYRICA 52 24 72 52
AMOX TR-POTASSIUM CLAVULANATE 51 32 75 135
DILTIAZEM ER 51 36 75 134
PEN NEEDLE 50 23 77 136
DIOVAN 50 20 77 55
AMLODIPINE BESYLATE-BENAZEPRIL 50 0 77 50
BUSPIRONE HCL 50 32 77 125
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 27, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.